Repurposed Therapies, New Compounds to Be Tested to Block Brain Inflammation in Parkinson’s

Repurposed Therapies, New Compounds to Be Tested to Block Brain Inflammation in Parkinson’s
Researchers in Australia are planning to test therapies already being used in other inflammatory conditions, as well as new compounds, for their potential to block brain inflammation and halt Parkinson’s disease progression. Conducted by researchers at The University of Queensland (UQ) in Australia, the study, “Pharmacological Targeting of Inflammasome Activation Mechanisms in Synuclein Models of Parkinson’s Disease,” is made possible by ... read more
Source: Parkinson’s News TodayPublished on 2019-03-11By Jose Marques Lopes, PhD